NanoCell Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$10M
- Investors
-
6
NanoCell Therapeutics General Information
Description
Developer of in-vivo gene therapies designed to treat oncology and autoimmune diseases. The company's technology leverages a non-viral DNA-based platform and cell-directed lipid nanoparticles to modify immune-effector cells directly within the patient, providing a treatment method that eliminates ex-vivo cell manipulation and improves the scalability and affordability of car-t therapies.
Contact Information
Website
www.nanocelltx.comCorporate Office
- 1055 Westlakes Drive
- 3rd floor
- Berwyn, PA 19312
- United States
Corporate Office
- 1055 Westlakes Drive
- 3rd floor
- Berwyn, PA 19312
- United States
NanoCell Therapeutics Timeline
NanoCell Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 16-Jun-2025 | $10M | Completed | Generating Revenue | ||
| 2. Grant | 04-Jan-2023 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2021 | Completed | Startup |
NanoCell Therapeutics Patents
NanoCell Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024133600-A1 | Integrating and self-inactivating viral vectors and constructs and uses thereof | Inactive | 20-Dec-2022 |
NanoCell Therapeutics Signals
NanoCell Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Institute for Follicular Lymphoma Innovation | Not-For-Profit Venture Capital | Minority | ||
| Imperial College London | University | |||
| Karolinska Institutet Holding | Holding Company | |||
| Sintef | Corporation | |||
| Utrecht University | University |
NanoCell Therapeutics FAQs
-
When was NanoCell Therapeutics founded?
NanoCell Therapeutics was founded in 2021.
-
Where is NanoCell Therapeutics headquartered?
NanoCell Therapeutics is headquartered in Berwyn, PA.
-
What is the size of NanoCell Therapeutics?
NanoCell Therapeutics has 16 total employees.
-
What industry is NanoCell Therapeutics in?
NanoCell Therapeutics’s primary industry is Drug Discovery.
-
Is NanoCell Therapeutics a private or public company?
NanoCell Therapeutics is a Private company.
-
What is NanoCell Therapeutics’s current revenue?
The current revenue for NanoCell Therapeutics is .
-
How much funding has NanoCell Therapeutics raised over time?
NanoCell Therapeutics has raised $10M.
-
Who are NanoCell Therapeutics’s investors?
Institute for Follicular Lymphoma Innovation, Imperial College London, Karolinska Institutet Holding, Sintef, and Utrecht University are 5 of 6 investors who have invested in NanoCell Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process